Evidence map›Paper›PMID 27802348›Full record

ArticlePloS one2016

Major Neutrophilia Observed in Acute Phase of Human Leptospirosis Is Not Associated with Increased Expression of Granulocyte Cell Activation Markers.

Loic Raffray, Claude Giry, David Vandroux, Barbara Kuli, Andry Randrianjohany, Anne-Marie Pequin, Frédéric Renou, Marie-Christine Jaffar-Bandjee, Philippe Gasque

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Arsenal ofAntioxidants (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Review
  6. Elevated levels of IL-8 in fatal leptospirosis.Pathogens and global health · 2020
    Article
  7. Phagocyte Escape ofFrontiers in immunology · 2020
    Review
  8. Article
  9. Observational
  10. Article
  11. Role of Murine Complement Component C5 in AcuteFrontiers in cellular and infection microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Loic RaffrayUniversité de La Réunion, CNRS 9192, INSERM U1187, IRD 249, CHU de La Réunion, Unité Mixte Processus Infectieux en Milieu Insulaire Tropical (PIMIT), Plateforme Technologique CYROI, Sainte-Clotilde, La Réunion, France.
Claude GiryUniversité de La Réunion, CNRS 9192, INSERM U1187, IRD 249, CHU de La Réunion, Unité Mixte Processus Infectieux en Milieu Insulaire Tropical (PIMIT), Plateforme Technologique CYROI, Sainte-Clotilde, La Réunion, France.
David VandrouxIntensive Care Unit, CHU La Réunion site Félix Guyon, St Denis, La Réunion, France.
Barbara KuliInfectious Diseases Unit, CHU La Réunion site Félix Guyon, St Denis, La Réunion, France.
Andry RandrianjohanyInternal Medicine Unit, GHER Hospital, St Benoit, La Réunion, France.
Anne-Marie PequinHematology laboratory, CHU La Réunion site Félix Guyon, St Denis, La Réunion, France.
Frédéric RenouInternal Medicine Unit, CHU La Réunion site Félix Guyon, St Denis, La Réunion, France.
Marie-Christine Jaffar-BandjeeUniversité de La Réunion, CNRS 9192, INSERM U1187, IRD 249, CHU de La Réunion, Unité Mixte Processus Infectieux en Milieu Insulaire Tropical (PIMIT), Plateforme Technologique CYROI, Sainte-Clotilde, La Réunion, France.
Philippe GasqueUniversité de La Réunion, CNRS 9192, INSERM U1187, IRD 249, CHU de La Réunion, Unité Mixte Processus Infectieux en Milieu Insulaire Tropical (PIMIT), Plateforme Technologique CYROI, Sainte-Clotilde, La Réunion, France.
Centre Hospitalier Universitaire de La Réunion · FRCentre National de la Recherche Scientifique · FRInstitut de Recherche pour le Développement · FRProcessus Infectieux en Milieu Insulaire Tropical · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has long been known that pathogenic Leptospira can mobilize the immune system but the specific contribution of neutrophils to control the infectious challenge remains to be clarified. We herein analyzed the phenotype of circulating neutrophils of patients with leptospirosis and healthy controls for the expression of toll-like receptor (TLR) type 2 (TLR2, to sense the leptospiral LPS) and several activation markers: interleukin 8 chemokine receptor CD182 (CXCR2), CD11b of the integrin/opsonin complement receptor type 3 (CR3) and CD15 (ligand of the selectin). The plasmatic level of the main CD182 ligand, interleukin 8 (CXCL8), was measured by ELISA. Hospitalized leptospirosis cases showed marked neutrophilia, particularly in the most severe cases. Interestingly, TLR2 was significantly increased in leptospirosis but identical levels of CD182 and CD11b were detected when compared to controls. CD15 was significantly decreased on neutrophils in leptospirosis but returned to normal within 1 month. Basal levels of IL-8 were measured in control subjects and were not increased in leptospirosis cases at the initial stage of the disease. In conclusion, we observed that neutrophils failed to regulate the expression of several of the receptors involved in cell activation and recruitment. This study further emphasizes the paradigm that neutrophils may be impaired in their overall capacity to thwart bacterial infection in leptospirosis patients.

Indexed as

Acute DiseaseAdultBiomarkersFemaleGene Expression RegulationGranulocytesHumansLeptospirosisMaleMiddle AgedNeutrophilsToll-Like Receptor 2BiomarkersTLR2 protein, humanToll-Like Receptor 2

Identifiers

PMID27802348
PMCPMC5089758
OpenAlexW2546947078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.